Treatment and prevention of retinal edema with dopaminergic anta

Details Treatment and prevention of retinal edema with dopaminergic anta Treatment and prevention of retinal edema with dopaminergic anta

1986-10-24

1989-12-12

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514211, 5142248, 514437, 514474, A61K 31445, A61K 3154, A61K 3138, A61K 3134

Patent

active

048868159

ABSTRACT:
Retinal edema, in particular cystoid macular edema, is prevented or treated by administering to the patient afflicted with retinal edema or in danger of experiencing retinal edema an amount of a dopaminergic antagonist effective to reduce the edema. A preferred dopaminergic antagonist is haloperidol. The activity of the dopaminergic antagonist may be potentiated by concurrent administration of ascorbic acid.

REFERENCES:
patent: 4088755 (1978-05-01), Inanaga et al.
patent: 4166853 (1979-09-01), McCall
patent: 4201706 (1980-05-01), Trager et al.
patent: 4443441 (1984-04-01), Galin
patent: 4505909 (1985-03-01), Bernstein
patent: 4620979 (1986-11-01), Schachar
The Pharmacological Basis of Therapeutics, pp. 546-558--1966.
Investigative Ophthal. & Visual Sci., vol. 16 (5), May--1977--pp. 381-392.
Chem. Abst., 108:88048(d) (1988)--Scornil et al.
Chem. Abstr. 82:93297h (1975)--Tuck.
Chem. Abstr. 87:3625q (1977)--Tso et al.
Chem. Abstr. 88:32029z (1978)--Scatton et al.
Chem. Abstr. 89:12149f (1978)--Lapinet et al.
Chem. Abstr. 93:143069k (1980)--Magnistretti et al.
Chem. Abstr. 101:48632p (1984)--Chion.
Chem. Abstr. 101:108722s (1984)--Sears.
Fung, W. E., Ophthalmology 89(8), 898-901 (1982).
Jampol, L. M., Ophthalmology 89(8), 891-897 (1982).
Rebec, G. V. et al., Science 227, 438-440 (1985).
Remington's Pharmaceutical Sciences, 16th Ed., A. Osol, Ed., Mack Publishing Co., Easton, Pa., 1980, pp. 1029-1037.

Affiliated with

Also associated with

Rating

Treatment and prevention of retinal edema with dopaminergic anta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment and prevention of retinal edema with dopaminergic anta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment and prevention of retinal edema with dopaminergic anta will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2121886